Antiplatelet Therapy in Patients With Coronary Stents Undergoing Elective Noncardiac Surgery: Continue, Stop, or Something in Between?

JAMA. 2017 Jul 11;318(2):120-121. doi: 10.1001/jama.2017.7845.

Authors

Christopher P Childers¹, Melinda Maggard-Gibbons², Paul G Shekelle³

Affiliations

¹ Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California.
² Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California2Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.
³ Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.

PMID: 28628711
DOI: 10.1001/jama.2017.7845

No abstract available

MeSH terms

Drug-Eluting Stents
Elective Surgical Procedures*
Heart Diseases / etiology*
Humans
Platelet Aggregation Inhibitors / administration & dosage
Platelet Aggregation Inhibitors / adverse effects*
Postoperative Complications / etiology
Postoperative Hemorrhage / chemically induced
Randomized Controlled Trials as Topic
Stents* / adverse effects

Substances

Platelet Aggregation Inhibitors

Grants and funding

F32 HS025079/HS/AHRQ HHS/United States